{"gene":"ABCC8","run_date":"2026-04-28T17:12:36","timeline":{"discoveries":[{"year":2006,"finding":"Activating mutations in ABCC8 (encoding SUR1) cause neonatal diabetes by elevating the basal magnesium-nucleotide-dependent stimulatory action of SUR1 on the Kir6.2 pore, resulting in markedly higher K(ATP) channel open probability in intact cells at physiological MgATP concentrations; these overactive channels remain sensitive to sulfonylurea blockade.","method":"Electrophysiological patch-clamp of mutant vs. wild-type K(ATP) channels in intact cells; clinical mutation screening of 34 neonatal diabetes patients","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 1-2 — functional electrophysiology of mutant channels with clinical correlation, replicated across multiple mutations","pmids":["16885549"],"is_preprint":false},{"year":1999,"finding":"SUR1 (ABCC8) binds ATP at NBF1 and ADP at NBF2, with the two nucleotide-binding folds working cooperatively; ADP binding/hydrolysis at SUR1 activates the K(ATP) channel, counterbalancing ATP-mediated inhibition through Kir6.2, thereby coupling metabolic state to channel activity.","method":"Biochemical nucleotide-binding and ATPase assays; functional reconstitution of K(ATP) channels with mutagenesis of NBF domains","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution and mechanistic model supported by multiple experimental approaches, widely cited foundational paper","pmids":["10581363"],"is_preprint":false},{"year":2004,"finding":"Loss-of-function ABCC8 mutations causing congenital hyperinsulinism alter intracellular trafficking of the SUR1/Kir6.2 channel complex, preventing its delivery to the plasma membrane, as shown by photolabeling studies in a reconstituted system.","method":"Photolabeling studies with reconstituted system; functional electrophysiology of beta-cells from patients; direct sequencing of all ABCC8 coding exons","journal":"The Journal of clinical endocrinology and metabolism","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted system photolabeling plus direct functional studies in patient beta-cells","pmids":["15579781"],"is_preprint":false},{"year":2008,"finding":"Diabetogenic activating mutations in SUR1 (ABCC8) cause MgATP-dependent hyper-stimulation that compromises K(ATP) channel metabolic sensing; channel hyperactivity rises exponentially with the number of mutant SUR subunits, and these channels show attenuated tolbutamide inhibition under stimulatory conditions.","method":"Electrophysiological analysis of Kir6.2-based channels reconstituted with mutant SUR1 subunits; dose-response analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution plus mutagenesis with quantitative functional readout in single study","pmids":["18281290"],"is_preprint":false},{"year":2015,"finding":"SUR1 NBF1 and NBF2 mediate nucleotide activation of the K(ATP) channel through an equilibrium allosteric mechanism; ATP/ADP binding to Kir6.2 inhibits the channel while Mg-nucleotide interactions with SUR activate it, and an allosteric model accounts for this dual regulation.","method":"Review synthesizing patch-clamp electrophysiology, mutagenesis, and equilibrium binding data; mechanistic allosteric modeling","journal":"Biophysical journal","confidence":"High","confidence_rationale":"Tier 1 — synthesis of multiple rigorous electrophysiological and mutagenesis experiments with mechanistic model","pmids":["26682803"],"is_preprint":false},{"year":2007,"finding":"Deletion of SUR1 NBF1 severely impairs K(ATP) channel expression (reducing total SUR1 protein levels suggesting increased degradation) and abolishes MgADP stimulation; NBF1 plays a role in channel expression regulation independent of the ER retention checkpoint and proteasomal degradation pathway.","method":"Electrophysiology of reconstituted K(ATP) channels with NBF1 deletion constructs; Western blotting; proteasomal inhibitor (MG-132) treatment; 'split' SUR1 constructs","journal":"Channels (Austin, Tex.)","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with deletion mutagenesis plus multiple orthogonal methods","pmids":["18708750"],"is_preprint":false},{"year":2013,"finding":"EPAC (Exchange Protein Activated by cAMP) binds directly to the intracellular loop of SUR1 (ABCC8) at amino acids 859-881; EPAC-SUR1 interaction reduces KATP channel open probability, and ablation of EPAC or expression of the binding-intercepting peptide SUR1(859-881) increases channel open probability, inhibiting glutamate release and reducing seizure vulnerability.","method":"Co-immunoprecipitation/direct binding assay; electrophysiology; in vivo mouse seizure model; dominant-negative peptide expression","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding identification plus functional electrophysiology and in vivo epistasis","pmids":["23678128"],"is_preprint":false},{"year":2017,"finding":"SUR1 (ABCC8) physically co-assembles with TRPM4 and AQP4 to form a novel heteromultimeric water/ion channel complex (SUR1-TRPM4-AQP4); the full tripartite complex is required for fast, high-capacity transmembrane water transport driving cell swelling; in a murine brain edema model, astrocytes upregulate SUR1-TRPM4, AQP4 co-associates with SUR1-TRPM4, and genetic inactivation of the SUR1-TRPM4-AQP4 solute pore blocks astrocyte swelling in vivo.","method":"Co-immunoprecipitation; Förster resonance energy transfer (FRET); calcein fluorescence cell-swelling assay in COS-7 cells; in vivo murine cold-injury model with diolistic labeling; genetic knockout","journal":"Glia","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (FRET, co-IP, reconstitution in heterologous cells, in vivo KO) in a single study","pmids":["28906027"],"is_preprint":false},{"year":2015,"finding":"SUR1 (ABCC8) co-localizes and co-associates with TRPM4 in human cerebral infarct neurons and endothelial cells; TRPM4 is transcriptionally upregulated after ischemia; pharmacologic blockade of SUR1 by glibenclamide mitigates perivascular TNF labeling in a rat stroke model.","method":"Immunohistochemistry and co-immunoprecipitation in postmortem human brain; in situ hybridization; rat middle cerebral artery occlusion model with pharmacologic inhibition","journal":"Journal of neuropathology and experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-immunoprecipitation in human tissue plus animal model pharmacology, single lab","pmids":["26172285"],"is_preprint":false},{"year":2023,"finding":"In perivascular astrocyte endfeet following ischemic stroke, SUR1-TRPM4 upregulation mediates Na+ influx, which drives reverse-mode NCX1 to elevate intracellular Ca2+, causing calmodulin-dependent AQP4 translocation to the plasma membrane and water influx, leading to cellular edema and brain swelling; astrocyte-specific deletion of SUR1-TRPM4 or NCX1 reduces brain swelling and improves neurological function.","method":"Mouse model of severe ischemic stroke; astrocyte-specific conditional knockout; pharmacological inhibition; calcium imaging; AQP4 surface localization assays","journal":"Science signaling","confidence":"High","confidence_rationale":"Tier 1-2 — cell-type-specific genetic deletion plus pharmacological rescue with defined mechanistic pathway in vivo","pmids":["37279286"],"is_preprint":false},{"year":2022,"finding":"SUR1-TRPM4 activation in BV2 microglia requires P2X7 receptor-mediated Ca2+ influx; SUR1-TRPM4-driven Na+ influx amplifies K+ efflux through K+ channels, leading to NLRP3 inflammasome activation; glibenclamide blocks SUR1-TRPM4 to inhibit this pathway and exerts direct anti-inflammatory neuroprotection independent of its anti-edema role.","method":"BV2 cell OGD/reperfusion and LPS models; Trpm4 siRNA knockdown; pharmacological inhibition with glibenclamide and 9-phenanthrol; Western blotting; rat cardiac arrest model","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown plus pharmacological inhibition with defined pathway, single lab","pmids":["35972671"],"is_preprint":false},{"year":2012,"finding":"SUR1 does not functionally or structurally associate with TRPM4 in COSm6 cells; TRPM4 currents are Ca2+-activated, ATP-inhibited, and insensitive to glibenclamide/tolbutamide regardless of SUR1 co-transfection; no FRET signal was detected between TRPM4 and SUR1, contrasting with efficient FRET between Kir6.2 and SUR1.","method":"Electrophysiology patch-clamp in COSm6 cells; FRET with fluorophore-tagged subunits; co-transfection of Kir6.2, SUR1, and TRPM4","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — reconstitution with FRET and electrophysiology, but contradicts other published work (moderate)","pmids":["22291026"],"is_preprint":false},{"year":2018,"finding":"Loss-of-function missense variants in ABCC8 are associated with pulmonary arterial hypertension; all evaluated ABCC8 variants decreased K(ATP) channel function in patch-clamp and rubidium flux assays in COS cells, and channel currents were pharmacologically rescued by the SUR1 activator diazoxide.","method":"Exome sequencing; patch-clamp electrophysiology; rubidium flux analysis in COS cells; pharmacological rescue with diazoxide","journal":"Circulation. Genomic and precision medicine","confidence":"High","confidence_rationale":"Tier 1-2 — functional assays (patch clamp + Rb flux) on multiple variants with pharmacological rescue","pmids":["30354297"],"is_preprint":false},{"year":2007,"finding":"Combining two ABCC8 coding mutations (D1193V and R1436Q) on a single allele causes intracellular retention of the SUR1/Kir6.2 channel complex, whereas each mutation individually results in plasma membrane-localized channels; separately, G228D and D1471N mutations in cis also cause intracellular retention and loss of K(ATP) channel function.","method":"Functional electrophysiology; intracellular localization studies of channel complex trafficking","journal":"Clinical endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — functional studies in heterologous expression system with defined cellular phenotype, single lab","pmids":["17466004"],"is_preprint":false},{"year":2010,"finding":"Activating mutations in ABCC8 account for approximately 40% of permanent neonatal diabetes cases; the K(ATP) channel composed of SUR1 and Kir6.2 is a key regulator of insulin release, with SUR1 mutations causing gain-of-channel function leading to persistent channel opening and failure of glucose-stimulated insulin secretion.","method":"Mutation screening; functional studies; clinical review","journal":"Reviews in endocrine & metabolic disorders","confidence":"Medium","confidence_rationale":"Tier 2 — review synthesizing multiple functional studies, widely replicated finding","pmids":["20922570"],"is_preprint":false},{"year":2017,"finding":"An ABCC8 homozygous nonsense mutation (p.Glu747*) in exon 17 causes neonatal diabetes through absence of full-length SUR1 mRNA and expression of an alternatively spliced transcript lacking exon 17; the truncated transcript enhances K(ATP) channel sensitivity to Mg-ADP/ATP, representing a gain-of-function through altered splicing rather than typical gain-of-function missense mutation.","method":"RNA studies confirming absence of full-length transcript and presence of alternatively spliced form; clinical sulfonylurea transfer","journal":"Journal of clinical research in pediatric endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 — RNA mechanistic studies with clinical functional validation, single report","pmids":["28663158"],"is_preprint":false},{"year":2013,"finding":"Inhibition of SUR1 by glyburide decreases vascular permeability of cerebral metastases and reduces ZO-1 gap formation in endothelial cells, suggesting SUR1 modulates blood-tumor barrier integrity through regulation of tight junction protein ZO-1.","method":"Dynamic contrast-enhanced MRI of blood-tumor barrier permeability; immunofluorescence and Western blot for SUR1 and ZO-1; in vivo rat intracranial tumor model","journal":"Neoplasia (New York, N.Y.)","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo pharmacological study with defined molecular readout (ZO-1), single lab","pmids":["23633925"],"is_preprint":false},{"year":2022,"finding":"Abcc8/SUR1 gene encodes alternatively spliced short isoforms (~65 kDa) in addition to the full-length protein; immunoprecipitation assays demonstrate that SUR2 short forms are part of functional channels coexisting with typical receptor forms, and SUR1 short forms alter ATP affinity; expression of SUR1 variants may be induced by brain conditions with decreased ATP (stroke, epilepsy).","method":"Western blotting with sulfonylurea binding assays; immunoprecipitation; review of experimental data","journal":"Neural regeneration research","confidence":"Low","confidence_rationale":"Tier 3 — review synthesizing indirect evidence, identity of short forms not fully clarified","pmids":["34380876"],"is_preprint":false},{"year":2014,"finding":"Targeted deletion of Sur1/Abcc8 specifically in glucagon-expressing alpha-cells using a Cre-lox approach demonstrates that KATP channels play a regulatory role in pancreatic alpha-cells, with ~41-64% recombination efficiency depending on allele configuration.","method":"Conditional knockout (Abcc8 flox mice crossed with GCG-Cre); agonist-resistance quantification; ROSA-EYFP reporter","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — clean conditional KO with quantified phenotype in defined cell type","pmids":["24621811"],"is_preprint":false},{"year":2021,"finding":"ABCC8-deficient (ABCC8V187D homozygous) iPSC-derived beta-like cells secrete 3.2-fold more insulin in low glucose and fail to respond to K(ATP) channel-acting drugs; loss of SUR1 increases SC-beta cell proliferation by 61% and this proliferative phenotype is recapitulated by pharmacological K(ATP) channel inactivation in SUR1-corrected cells, revealing a novel role for K(ATP) channel activity during human islet development.","method":"iPSC differentiation; CRISPR-Cas9 mutation correction; insulin secretion assays; in vivo mouse xenograft; pharmacological K(ATP) channel manipulation","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1-2 — isogenic iPSC model with pharmacological rescue confirming mechanism, multiple functional readouts","pmids":["33404684"],"is_preprint":false}],"current_model":"ABCC8 encodes SUR1, the regulatory ABC-transporter subunit of the K(ATP) channel (SUR1/Kir6.2 octamer), which senses cellular metabolic state by binding MgATP at NBF1 and MgADP at NBF2 to activate channel opening, counterbalancing ATP-mediated inhibition of Kir6.2, thereby coupling beta-cell metabolism to insulin secretion; gain-of-function mutations cause neonatal diabetes and MODY by hyper-stimulating the channel, while loss-of-function mutations cause congenital hyperinsulinism through impaired channel trafficking or function; in the CNS, SUR1 additionally associates with TRPM4 (and AQP4) to form cation channels in neurons and astrocytes that drive cytotoxic edema after injury, and SUR1-TRPM4-mediated Na+ influx signals through NCX1 and calmodulin to translocate AQP4 to the plasma membrane, amplifying water influx and brain swelling."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing how SUR1 senses metabolic state resolved the fundamental question of how an ABC transporter subunit couples nucleotide hydrolysis to ion channel gating: ATP binds NBF1 and ADP binds NBF2, with cooperative Mg-nucleotide interactions at SUR1 activating the channel to counterbalance ATP inhibition at Kir6.2.","evidence":"Biochemical nucleotide-binding/ATPase assays and functional reconstitution with NBF mutagenesis","pmids":["10581363"],"confidence":"High","gaps":["Structural basis of NBF1–NBF2 cooperativity not resolved at atomic level","Stoichiometry of nucleotide occupancy states in the intact octamer unclear"]},{"year":2004,"claim":"Demonstrating that loss-of-function ABCC8 mutations cause congenital hyperinsulinism by trapping the SUR1/Kir6.2 complex intracellularly established that SUR1 controls channel trafficking in addition to gating, explaining a disease mechanism distinct from altered nucleotide sensitivity.","evidence":"Photolabeling in reconstituted system plus electrophysiology in patient beta cells","pmids":["15579781"],"confidence":"High","gaps":["Specific ER quality-control machinery recognizing misfolded SUR1 not identified","Whether trafficking-defective mutants retain partial function if forced to the surface not systematically tested"]},{"year":2006,"claim":"Identifying activating ABCC8 mutations in neonatal diabetes patients showed that enhanced Mg-nucleotide-dependent stimulation of SUR1 is sufficient to hold channels open and prevent insulin secretion, establishing the gain-of-function disease mechanism and demonstrating sulfonylurea sensitivity of mutant channels.","evidence":"Patch-clamp electrophysiology of mutant channels in intact cells; mutation screening of 34 neonatal diabetes patients","pmids":["16885549"],"confidence":"High","gaps":["Precise conformational change linking NBF activation to pore opening unknown","Genotype–phenotype correlations for sulfonylurea responsiveness incomplete"]},{"year":2007,"claim":"Deletion of NBF1 revealed that this domain is required not only for MgADP-dependent channel activation but also for stable SUR1 protein expression via a pathway independent of the ER retention checkpoint, showing NBF1 has a structural/stability role beyond nucleotide sensing.","evidence":"Electrophysiology of reconstituted split-SUR1 constructs; Western blotting with proteasomal inhibitor treatment","pmids":["18708750"],"confidence":"High","gaps":["Degradation pathway for NBF1-deleted SUR1 not identified","Whether NBF1 directly mediates protein folding or chaperone recruitment unknown"]},{"year":2008,"claim":"Quantitative reconstitution of channels with varying numbers of mutant SUR1 subunits showed that hyperactivity rises exponentially with mutant subunit number and that tolbutamide inhibition is attenuated under stimulatory conditions, explaining variable clinical severity and sulfonylurea dose requirements.","evidence":"Electrophysiological dose-response analysis of Kir6.2-based channels with graded mutant SUR1","pmids":["18281290"],"confidence":"High","gaps":["In vivo subunit stoichiometry in patient beta cells not directly measured","Whether heterozygous activating mutations produce clinically relevant hyperactivity not fully resolved"]},{"year":2013,"claim":"Discovery that EPAC binds directly to the SUR1 intracellular loop (aa 859–881) and reduces K(ATP) open probability revealed a cAMP-dependent regulatory input to channel gating, linking incretin signaling to channel modulation in neurons and affecting seizure susceptibility.","evidence":"Co-immunoprecipitation, direct binding assay, electrophysiology, and in vivo mouse seizure model with dominant-negative peptide","pmids":["23678128"],"confidence":"High","gaps":["Whether EPAC–SUR1 interaction occurs in pancreatic beta cells and affects insulin secretion not tested","Structural basis of EPAC docking on the intracellular loop unknown"]},{"year":2015,"claim":"Co-immunoprecipitation and co-localization of SUR1 with TRPM4 in postmortem human stroke tissue, together with earlier negative FRET data in heterologous cells, framed a contested question about whether SUR1 physically associates with TRPM4 in a pathophysiologically relevant context.","evidence":"Co-IP and immunohistochemistry in human cerebral infarct tissue; pharmacological inhibition in rat stroke model; prior negative FRET in COSm6 cells","pmids":["26172285","22291026"],"confidence":"Medium","gaps":["Contradictory FRET results in COSm6 cells versus co-IP in native tissue not reconciled","Whether an intermediate adaptor mediates the SUR1–TRPM4 interaction not excluded","Single-lab co-IP in tissue without reciprocal pulldown"]},{"year":2017,"claim":"Demonstration that SUR1, TRPM4, and AQP4 form a tripartite heteromultimeric complex required for high-capacity water transport resolved how SUR1 participates in cytotoxic edema beyond simple ion flux, and genetic ablation confirmed the complex's necessity for astrocyte swelling in vivo.","evidence":"Co-IP, FRET, calcein cell-swelling assay in COS-7 cells, and in vivo murine cold-injury model with genetic knockout","pmids":["28906027"],"confidence":"High","gaps":["Stoichiometry and architecture of the SUR1-TRPM4-AQP4 complex not structurally resolved","Whether the tripartite complex forms in non-CNS tissues unknown"]},{"year":2018,"claim":"Identification of loss-of-function ABCC8 variants in pulmonary arterial hypertension patients, with functional rescue by diazoxide, extended K(ATP) channel pathophysiology beyond endocrine disease to vascular biology.","evidence":"Exome sequencing; patch-clamp and rubidium flux assays in COS cells; pharmacological rescue","pmids":["30354297"],"confidence":"High","gaps":["Mechanism linking reduced K(ATP) current to pulmonary vascular remodeling not delineated","Whether SUR1 or SUR2 predominates in pulmonary vascular smooth muscle not clarified"]},{"year":2021,"claim":"Using isogenic iPSC-derived beta cells showed that ABCC8 deficiency increases both basal insulin secretion and beta-cell proliferation, with the proliferative phenotype recapitulated by pharmacological K(ATP) blockade, revealing a developmental role for K(ATP) channel activity in human islet biology.","evidence":"iPSC differentiation with CRISPR-Cas9 correction; insulin secretion assays; in vivo xenograft; pharmacological manipulation","pmids":["33404684"],"confidence":"High","gaps":["Signaling pathway linking K(ATP) channel closure to proliferation not identified","Whether proliferative effect persists in mature beta cells unknown"]},{"year":2023,"claim":"A complete signaling cascade was mapped in perivascular astrocyte endfeet: SUR1-TRPM4 Na⁺ influx → reverse-mode NCX1 → Ca²⁺ rise → calmodulin-dependent AQP4 translocation → water influx and edema, establishing the molecular logic by which SUR1-TRPM4 amplifies brain swelling after stroke.","evidence":"Astrocyte-specific conditional knockout of SUR1-TRPM4 and NCX1 in mouse ischemic stroke model; calcium imaging; AQP4 surface localization assays","pmids":["37279286"],"confidence":"High","gaps":["Whether this cascade operates in non-astrocytic CNS cell types not tested","Calmodulin target on AQP4 or intermediate kinase not identified","Relative contribution of this pathway versus other edema mechanisms not quantified"]},{"year":null,"claim":"Despite detailed functional understanding, high-resolution structural models of disease-mutant SUR1 channels and the SUR1-TRPM4-AQP4 complex are lacking, and the signaling pathways linking K(ATP) channel closure to beta-cell proliferation and pulmonary vascular remodeling remain uncharacterized.","evidence":"","pmids":[],"confidence":"High","gaps":["Atomic-resolution structures of activating/trafficking-defective SUR1 mutants needed","Mechanism coupling K(ATP) channel state to cell proliferation unknown","Reconciliation of contradictory SUR1-TRPM4 FRET data across expression systems unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[1,4,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,3,4,6]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[7,9]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,7,9,13]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[2,13]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[1,4,7,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,2,12,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,4,6]}],"complexes":["K(ATP) channel (SUR1/Kir6.2 octamer)","SUR1-TRPM4-AQP4 complex"],"partners":["KCNJ11","TRPM4","AQP4","RAPGEF3","SLC8A1"],"other_free_text":[]},"mechanistic_narrative":"ABCC8 encodes SUR1, the regulatory subunit of the octameric K(ATP) channel (SUR1/Kir6.2), which couples cellular metabolic state to membrane excitability by sensing Mg-nucleotides: ATP binding at NBF1 and ADP binding/hydrolysis at NBF2 activate the channel, counterbalancing ATP-mediated inhibition at Kir6.2, thereby controlling insulin secretion in pancreatic beta cells and glucagon release in alpha cells [PMID:10581363, PMID:26682803, PMID:24621811]. Gain-of-function mutations in ABCC8 cause neonatal diabetes by elevating MgATP-dependent channel open probability and impairing metabolic sensing, while loss-of-function mutations cause congenital hyperinsulinism through defective trafficking of the SUR1/Kir6.2 complex to the plasma membrane; both conditions remain responsive to sulfonylurea pharmacology [PMID:16885549, PMID:15579781, PMID:30354297]. In the central nervous system, SUR1 co-assembles with TRPM4 (and AQP4) to form a heteromultimeric cation/water channel complex in astrocytes, neurons, and endothelial cells after ischemic injury; SUR1-TRPM4-mediated Na⁺ influx drives reverse-mode NCX1 signaling, calmodulin-dependent AQP4 translocation to the plasma membrane, and consequent cytotoxic edema [PMID:28906027, PMID:37279286]. Loss-of-function ABCC8 variants also diminish K(ATP) channel currents in the pulmonary vasculature and are associated with pulmonary arterial hypertension [PMID:30354297]."},"prefetch_data":{"uniprot":{"accession":"Q09428","full_name":"ATP-binding cassette sub-family C member 8","aliases":["Sulfonylurea receptor 1"],"length_aa":1581,"mass_kda":177.0,"function":"Regulator subunit of pancreatic ATP-sensitive potassium channel (KATP), playing a major role in the regulation of insulin release. In pancreatic cells, it forms KATP channels with KCNJ11; KCNJ11 forms the channel pore while ABCC8 is required for activation and regulation","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q09428/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ABCC8","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ABCC8","total_profiled":1310},"omim":[{"mim_id":"621196","title":"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 12; MODY12","url":"https://www.omim.org/entry/621196"},{"mim_id":"618858","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM4","url":"https://www.omim.org/entry/618858"},{"mim_id":"618857","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 3; PNDM3","url":"https://www.omim.org/entry/618857"},{"mim_id":"618856","title":"DIABETES MELLITUS, PERMANENT NEONATAL, 2; PNDM2","url":"https://www.omim.org/entry/618856"},{"mim_id":"610582","title":"DIABETES MELLITUS, TRANSIENT NEONATAL, 3; TNDM3","url":"https://www.omim.org/entry/610582"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"},{"location":"Principal piece","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":22.2},{"tissue":"pancreas","ntpm":13.3},{"tissue":"pituitary gland","ntpm":23.3}],"url":"https://www.proteinatlas.org/search/ABCC8"},"hgnc":{"alias_symbol":["HI","PHHI","SUR1","MRP8","ABC36","HHF1","TNDM2"],"prev_symbol":["SUR","HRINS"]},"alphafold":{"accession":"Q09428","domains":[{"cath_id":"-","chopping":"9-207","consensus_level":"high","plddt":88.623,"start":9,"end":207},{"cath_id":"1.20.1560.10","chopping":"270-617_997-1041_1060-1320","consensus_level":"medium","plddt":89.1511,"start":270,"end":1320},{"cath_id":"3.40.50.300","chopping":"678-742_768-793_811-927","consensus_level":"medium","plddt":84.6252,"start":678,"end":927},{"cath_id":"3.40.50.300","chopping":"1334-1581","consensus_level":"high","plddt":84.8938,"start":1334,"end":1581}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q09428","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q09428-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q09428-F1-predicted_aligned_error_v6.png","plddt_mean":82.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ABCC8","jax_strain_url":"https://www.jax.org/strain/search?query=ABCC8"},"sequence":{"accession":"Q09428","fasta_url":"https://rest.uniprot.org/uniprotkb/Q09428.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q09428/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q09428"}},"corpus_meta":[{"pmid":"36525368","id":"PMC_36525368","title":"YaHS: yet another Hi-C scaffolding tool.","date":"2023","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/36525368","citation_count":1351,"is_preprint":false},{"pmid":"17767165","id":"PMC_17767165","title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.","date":"2007","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17767165","citation_count":1141,"is_preprint":false},{"pmid":"22652625","id":"PMC_22652625","title":"Hi-C: a comprehensive technique to capture the conformation of genomes.","date":"2012","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/22652625","citation_count":890,"is_preprint":false},{"pmid":"16885549","id":"PMC_16885549","title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.","date":"2006","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16885549","citation_count":467,"is_preprint":false},{"pmid":"24501021","id":"PMC_24501021","title":"Statistical confidence estimation for Hi-C data reveals regulatory chromatin contacts.","date":"2014","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/24501021","citation_count":360,"is_preprint":false},{"pmid":"28435001","id":"PMC_28435001","title":"Hi-C 2.0: An optimized Hi-C procedure for high-resolution genome-wide mapping of chromosome conformation.","date":"2017","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/28435001","citation_count":243,"is_preprint":false},{"pmid":"9920411","id":"PMC_9920411","title":"Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9).","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9920411","citation_count":231,"is_preprint":false},{"pmid":"34282151","id":"PMC_34282151","title":"Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34282151","citation_count":207,"is_preprint":false},{"pmid":"10464253","id":"PMC_10464253","title":"S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10464253","citation_count":176,"is_preprint":false},{"pmid":"20571523","id":"PMC_20571523","title":"Necrostatin decreases oxidative damage, inflammation, and injury after neonatal HI.","date":"2010","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20571523","citation_count":164,"is_preprint":false},{"pmid":"28906027","id":"PMC_28906027","title":"SUR1-TRPM4 and AQP4 form a heteromultimeric complex that amplifies ion/water osmotic coupling and drives astrocyte swelling.","date":"2017","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/28906027","citation_count":112,"is_preprint":false},{"pmid":"10965802","id":"PMC_10965802","title":"Dynamics of microglial activation after human traumatic brain injury are revealed by delayed expression of macrophage-related proteins MRP8 and MRP14.","date":"2000","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/10965802","citation_count":103,"is_preprint":false},{"pmid":"32470376","id":"PMC_32470376","title":"Hi-C Identifies Complex Genomic Rearrangements and TAD-Shuffling in Developmental Diseases.","date":"2020","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32470376","citation_count":91,"is_preprint":false},{"pmid":"25497086","id":"PMC_25497086","title":"Alarmins MRP8 and MRP14 induce stress tolerance in phagocytes under sterile inflammatory conditions.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/25497086","citation_count":90,"is_preprint":false},{"pmid":"7542868","id":"PMC_7542868","title":"Increase of calcium levels in epithelial cells induces translocation of calcium-binding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments.","date":"1995","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/7542868","citation_count":86,"is_preprint":false},{"pmid":"29685368","id":"PMC_29685368","title":"Principles of Chromosome Architecture Revealed by Hi-C.","date":"2018","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29685368","citation_count":85,"is_preprint":false},{"pmid":"24762056","id":"PMC_24762056","title":"Peptidylarginine deiminases: novel drug targets for prevention of neuronal damage following hypoxic ischemic insult (HI) in neonates.","date":"2014","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24762056","citation_count":83,"is_preprint":false},{"pmid":"2199095","id":"PMC_2199095","title":"Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an immunohistochemical study.","date":"1990","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/2199095","citation_count":83,"is_preprint":false},{"pmid":"26172285","id":"PMC_26172285","title":"Sur1-Trpm4 Cation Channel Expression in Human Cerebral Infarcts.","date":"2015","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26172285","citation_count":82,"is_preprint":false},{"pmid":"12937135","id":"PMC_12937135","title":"Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12937135","citation_count":70,"is_preprint":false},{"pmid":"12719414","id":"PMC_12719414","title":"Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12719414","citation_count":70,"is_preprint":false},{"pmid":"29244056","id":"PMC_29244056","title":"CscoreTool: fast Hi-C compartment analysis at high resolution.","date":"2018","source":"Bioinformatics (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29244056","citation_count":69,"is_preprint":false},{"pmid":"9845287","id":"PMC_9845287","title":"Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells.","date":"1998","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/9845287","citation_count":68,"is_preprint":false},{"pmid":"15579781","id":"PMC_15579781","title":"Hyperinsulinism of infancy: novel ABCC8 and KCNJ11 mutations and evidence for additional locus heterogeneity.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15579781","citation_count":66,"is_preprint":false},{"pmid":"30354297","id":"PMC_30354297","title":"Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.","date":"2018","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30354297","citation_count":65,"is_preprint":false},{"pmid":"30570701","id":"PMC_30570701","title":"Hi-C analysis: from data generation to integration.","date":"2018","source":"Biophysical reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30570701","citation_count":65,"is_preprint":false},{"pmid":"31536770","id":"PMC_31536770","title":"Sci-Hi-C: A single-cell Hi-C method for mapping 3D genome organization in large number of single cells.","date":"2019","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/31536770","citation_count":65,"is_preprint":false},{"pmid":"25957996","id":"PMC_25957996","title":"The Effect of miR-132, miR-146a, and miR-155 on MRP8/TLR4-Induced Astrocyte-Related Inflammation.","date":"2015","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/25957996","citation_count":65,"is_preprint":false},{"pmid":"20922570","id":"PMC_20922570","title":"Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.","date":"2010","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/20922570","citation_count":65,"is_preprint":false},{"pmid":"15579791","id":"PMC_15579791","title":"Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study.","date":"2004","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15579791","citation_count":58,"is_preprint":false},{"pmid":"14597726","id":"PMC_14597726","title":"Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis.","date":"2003","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/14597726","citation_count":56,"is_preprint":false},{"pmid":"36369226","id":"PMC_36369226","title":"dcHiC detects differential compartments across multiple Hi-C datasets.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36369226","citation_count":55,"is_preprint":false},{"pmid":"19835955","id":"PMC_19835955","title":"Mrp-8 and -14 mediate CNS injury in focal cerebral ischemia.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19835955","citation_count":53,"is_preprint":false},{"pmid":"10725790","id":"PMC_10725790","title":"The regulatory role of MRP8 (S100A8) and MRP14 (S100A9) in the transendothelial migration of human leukocytes.","date":"1999","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10725790","citation_count":52,"is_preprint":false},{"pmid":"25342131","id":"PMC_25342131","title":"Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25342131","citation_count":52,"is_preprint":false},{"pmid":"10581363","id":"PMC_10581363","title":"Comparative aspects of the function and mechanism of SUR1 and MDR1 proteins.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10581363","citation_count":51,"is_preprint":false},{"pmid":"10967257","id":"PMC_10967257","title":"Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo.","date":"2000","source":"FEMS immunology and medical microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/10967257","citation_count":50,"is_preprint":false},{"pmid":"35809047","id":"PMC_35809047","title":"Loop detection using Hi-C data with HiCExplorer.","date":"2022","source":"GigaScience","url":"https://pubmed.ncbi.nlm.nih.gov/35809047","citation_count":46,"is_preprint":false},{"pmid":"1524561","id":"PMC_1524561","title":"The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation.","date":"1992","source":"Behring Institute Mitteilungen","url":"https://pubmed.ncbi.nlm.nih.gov/1524561","citation_count":46,"is_preprint":false},{"pmid":"28159004","id":"PMC_28159004","title":"Software tools for visualizing Hi-C data.","date":"2017","source":"Genome biology","url":"https://pubmed.ncbi.nlm.nih.gov/28159004","citation_count":45,"is_preprint":false},{"pmid":"23633925","id":"PMC_23633925","title":"Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.","date":"2013","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23633925","citation_count":44,"is_preprint":false},{"pmid":"22265226","id":"PMC_22265226","title":"Chromosome organization in the nucleus - charting new territory across the Hi-Cs.","date":"2012","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/22265226","citation_count":43,"is_preprint":false},{"pmid":"9693055","id":"PMC_9693055","title":"Copurification of P6, MRP8, and MRP14 from human granulocytes and separation of individual proteins.","date":"1998","source":"Protein expression and purification","url":"https://pubmed.ncbi.nlm.nih.gov/9693055","citation_count":42,"is_preprint":false},{"pmid":"33575580","id":"PMC_33575580","title":"PHi-C: deciphering Hi-C data into polymer dynamics.","date":"2020","source":"NAR genomics and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/33575580","citation_count":40,"is_preprint":false},{"pmid":"30919130","id":"PMC_30919130","title":"The association between CD31hiEmcnhi endothelial cells and bone mineral density in Chinese women.","date":"2019","source":"Journal of bone and mineral metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30919130","citation_count":39,"is_preprint":false},{"pmid":"28450294","id":"PMC_28450294","title":"Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28450294","citation_count":38,"is_preprint":false},{"pmid":"37279286","id":"PMC_37279286","title":"Cation flux through SUR1-TRPM4 and NCX1 in astrocyte endfeet induces water influx through AQP4 and brain swelling after ischemic stroke.","date":"2023","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/37279286","citation_count":38,"is_preprint":false},{"pmid":"21182469","id":"PMC_21182469","title":"Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure.","date":"2010","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21182469","citation_count":32,"is_preprint":false},{"pmid":"16191197","id":"PMC_16191197","title":"The subcellular distribution of myeloid-related protein 8 (MRP8) and MRP14 in human neutrophils.","date":"2005","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16191197","citation_count":32,"is_preprint":false},{"pmid":"32311088","id":"PMC_32311088","title":"Deficit of circulating CD19+ CD24hi CD38hi regulatory B cells in severe aplastic anaemia.","date":"2020","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/32311088","citation_count":30,"is_preprint":false},{"pmid":"32924828","id":"PMC_32924828","title":"Defective CD19+CD24hiCD38hi transitional B-cell function in patients with relapsing-remitting MS.","date":"2020","source":"Multiple sclerosis (Houndmills, Basingstoke, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32924828","citation_count":29,"is_preprint":false},{"pmid":"14555857","id":"PMC_14555857","title":"Interleukin-10 influences the expression of MRP8 and MRP14 in human dendritic cells.","date":"2003","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14555857","citation_count":28,"is_preprint":false},{"pmid":"19021632","id":"PMC_19021632","title":"Mutations in the ABCC8 (SUR1 subunit of the K(ATP) channel) gene are associated with a variable clinical phenotype.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19021632","citation_count":28,"is_preprint":false},{"pmid":"24768178","id":"PMC_24768178","title":"ABCC8 genetic variants and risk of diabetes mellitus.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/24768178","citation_count":27,"is_preprint":false},{"pmid":"33404684","id":"PMC_33404684","title":"SUR1-mutant iPS cell-derived islets recapitulate the pathophysiology of congenital hyperinsulinism.","date":"2021","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/33404684","citation_count":27,"is_preprint":false},{"pmid":"29263322","id":"PMC_29263322","title":"NAIP/NLRC4 inflammasome activation in MRP8+ cells is sufficient to cause systemic inflammatory disease.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29263322","citation_count":27,"is_preprint":false},{"pmid":"35972671","id":"PMC_35972671","title":"Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia.","date":"2022","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/35972671","citation_count":27,"is_preprint":false},{"pmid":"32733885","id":"PMC_32733885","title":"BRG1 Stimulates Endothelial Derived Alarmin MRP8 to Promote Macrophage Infiltration in an Animal Model of Cardiac Hypertrophy.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32733885","citation_count":27,"is_preprint":false},{"pmid":"21716120","id":"PMC_21716120","title":"ABCC8 mutation allele frequency in the Ashkenazi Jewish population and risk of focal hyperinsulinemic hypoglycemia.","date":"2011","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21716120","citation_count":27,"is_preprint":false},{"pmid":"26682803","id":"PMC_26682803","title":"The Nucleotide-Binding Sites of SUR1: A Mechanistic Model.","date":"2015","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26682803","citation_count":26,"is_preprint":false},{"pmid":"11113873","id":"PMC_11113873","title":"Identification of MRP-8 (calgranulin A) as a major responsive protein in chronic periodontitis.","date":"2000","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11113873","citation_count":26,"is_preprint":false},{"pmid":"11737516","id":"PMC_11737516","title":"Quantitative analysis of MRP-8 in gingival crevicular fluid in periodontal health and disease using microbore HPLC.","date":"2001","source":"Journal of clinical periodontology","url":"https://pubmed.ncbi.nlm.nih.gov/11737516","citation_count":25,"is_preprint":false},{"pmid":"33893353","id":"PMC_33893353","title":"VEHiCLE: a Variationally Encoded Hi-C Loss Enhancement algorithm for improving and generating Hi-C data.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33893353","citation_count":25,"is_preprint":false},{"pmid":"22291026","id":"PMC_22291026","title":"On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22291026","citation_count":24,"is_preprint":false},{"pmid":"32934261","id":"PMC_32934261","title":"Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32934261","citation_count":23,"is_preprint":false},{"pmid":"10722871","id":"PMC_10722871","title":"MRP8/MRP14, CD11b and HLA-DR expression of alveolar macrophages in pneumonia.","date":"2000","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/10722871","citation_count":22,"is_preprint":false},{"pmid":"29723572","id":"PMC_29723572","title":"Iteratively improving Hi-C experiments one step at a time.","date":"2018","source":"Methods (San Diego, Calif.)","url":"https://pubmed.ncbi.nlm.nih.gov/29723572","citation_count":22,"is_preprint":false},{"pmid":"32460863","id":"PMC_32460863","title":"Characterization of splenic MRC1hiMHCIIlo and MRC1loMHCIIhi cells from the monocyte/macrophage lineage of White Leghorn chickens.","date":"2020","source":"Veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/32460863","citation_count":22,"is_preprint":false},{"pmid":"32863956","id":"PMC_32863956","title":"HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32863956","citation_count":21,"is_preprint":false},{"pmid":"27199743","id":"PMC_27199743","title":"SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson.","date":"2016","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27199743","citation_count":21,"is_preprint":false},{"pmid":"32758136","id":"PMC_32758136","title":"GSDB: a database of 3D chromosome and genome structures reconstructed from Hi-C data.","date":"2020","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32758136","citation_count":20,"is_preprint":false},{"pmid":"33743768","id":"PMC_33743768","title":"A cookbook for DNase Hi-C.","date":"2021","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/33743768","citation_count":19,"is_preprint":false},{"pmid":"23678128","id":"PMC_23678128","title":"EPAC inhibition of SUR1 receptor increases glutamate release and seizure vulnerability.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23678128","citation_count":19,"is_preprint":false},{"pmid":"17466004","id":"PMC_17466004","title":"Complex ABCC8 DNA variations in congenital hyperinsulinism: lessons from functional studies.","date":"2007","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17466004","citation_count":19,"is_preprint":false},{"pmid":"26955049","id":"PMC_26955049","title":"3D Genome Reconstruction with ShRec3D+ and Hi-C Data.","date":"2016","source":"IEEE/ACM transactions on computational biology and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/26955049","citation_count":18,"is_preprint":false},{"pmid":"31181422","id":"PMC_31181422","title":"Decreased number of CD19+CD24hiCD38hi regulatory B cells in Diabetic nephropathy.","date":"2019","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/31181422","citation_count":18,"is_preprint":false},{"pmid":"12590055","id":"PMC_12590055","title":"The time-dependent expression of fibronectin, MRP8, MRP14 and defensin in surgically treated human skin wounds.","date":"2003","source":"Forensic science international","url":"https://pubmed.ncbi.nlm.nih.gov/12590055","citation_count":17,"is_preprint":false},{"pmid":"31337548","id":"PMC_31337548","title":"Heterogeneous Loop Model to Infer 3D Chromosome Structures from Hi-C.","date":"2019","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31337548","citation_count":17,"is_preprint":false},{"pmid":"18281290","id":"PMC_18281290","title":"A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18281290","citation_count":17,"is_preprint":false},{"pmid":"31562829","id":"PMC_31562829","title":"Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy.","date":"2019","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/31562829","citation_count":16,"is_preprint":false},{"pmid":"32104147","id":"PMC_32104147","title":"CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis.","date":"2020","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/32104147","citation_count":16,"is_preprint":false},{"pmid":"32164155","id":"PMC_32164155","title":"The DLO Hi-C Tool for Digestion-Ligation-Only Hi-C Chromosome Conformation Capture Data Analysis.","date":"2020","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/32164155","citation_count":16,"is_preprint":false},{"pmid":"28179539","id":"PMC_28179539","title":"Smoking reduces circulating CD26hiCD161hi MAIT cells in healthy individuals and patients with multiple sclerosis.","date":"2017","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/28179539","citation_count":16,"is_preprint":false},{"pmid":"28600547","id":"PMC_28600547","title":"Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28600547","citation_count":16,"is_preprint":false},{"pmid":"34113823","id":"PMC_34113823","title":"CD27hiCD38hi plasmablasts are activated B cells of mixed origin with distinct function.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34113823","citation_count":16,"is_preprint":false},{"pmid":"24024896","id":"PMC_24024896","title":"ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression.","date":"2013","source":"Pharmacogenomics","url":"https://pubmed.ncbi.nlm.nih.gov/24024896","citation_count":15,"is_preprint":false},{"pmid":"34014594","id":"PMC_34014594","title":"ABCC8 variants in MODY12: Review of the literature and report of a case with severe complications.","date":"2021","source":"Diabetes/metabolism research and reviews","url":"https://pubmed.ncbi.nlm.nih.gov/34014594","citation_count":15,"is_preprint":false},{"pmid":"34871311","id":"PMC_34871311","title":"Extracting multi-way chromatin contacts from Hi-C data.","date":"2021","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/34871311","citation_count":14,"is_preprint":false},{"pmid":"36636344","id":"PMC_36636344","title":"Wolbachia RNase HI contributes to virus blocking in the mosquito Aedes aegypti.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/36636344","citation_count":14,"is_preprint":false},{"pmid":"24440297","id":"PMC_24440297","title":"The accumulation of macrophages expressing myeloid-related protein 8 (MRP8) and MRP14 in the spleen of BALB/cA mice during infection with Plasmodium berghei.","date":"2014","source":"Experimental parasitology","url":"https://pubmed.ncbi.nlm.nih.gov/24440297","citation_count":14,"is_preprint":false},{"pmid":"39692014","id":"PMC_39692014","title":"ACKR1hiECs Promote Aortic Dissection Through Adjusting Macrophage Behavior.","date":"2024","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/39692014","citation_count":13,"is_preprint":false},{"pmid":"24621811","id":"PMC_24621811","title":"Targeting SUR1/Abcc8-type neuroendocrine KATP channels in pancreatic islet cells.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24621811","citation_count":13,"is_preprint":false},{"pmid":"31707576","id":"PMC_31707576","title":"Serum SUR1 and TRPM4 in patients with subarachnoid hemorrhage.","date":"2019","source":"Neurosurgical review","url":"https://pubmed.ncbi.nlm.nih.gov/31707576","citation_count":13,"is_preprint":false},{"pmid":"18708750","id":"PMC_18708750","title":"Regulation of KATP channel expression and activity by the SUR1 nucleotide binding fold 1.","date":"2007","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18708750","citation_count":13,"is_preprint":false},{"pmid":"34380876","id":"PMC_34380876","title":"The short form of the SUR1 and its functional implications in the damaged brain.","date":"2022","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/34380876","citation_count":12,"is_preprint":false},{"pmid":"34631896","id":"PMC_34631896","title":"Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review.","date":"2021","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/34631896","citation_count":12,"is_preprint":false},{"pmid":"22381691","id":"PMC_22381691","title":"A role for MRP8 in in stent restenosis in diabetes.","date":"2012","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/22381691","citation_count":12,"is_preprint":false},{"pmid":"32080297","id":"PMC_32080297","title":"Ablation of Myeloid Cell MRP8 Ameliorates Nephrotoxic Serum-induced Glomerulonephritis by Affecting Macrophage Characterization through Intraglomerular Crosstalk.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32080297","citation_count":12,"is_preprint":false},{"pmid":"34319725","id":"PMC_34319725","title":"Chromosome Modeling on Downsampled Hi-C Maps Enhances the Compartmentalization Signal.","date":"2021","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/34319725","citation_count":12,"is_preprint":false},{"pmid":"28663158","id":"PMC_28663158","title":"An ABCC8 Nonsense Mutation Causing Neonatal Diabetes Through Altered Transcript Expression.","date":"2017","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28663158","citation_count":12,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46605,"output_tokens":4953,"usd":0.107055},"stage2":{"model":"claude-opus-4-6","input_tokens":8445,"output_tokens":3299,"usd":0.18705},"total_usd":0.294105,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"Activating mutations in ABCC8 (encoding SUR1) cause neonatal diabetes by elevating the basal magnesium-nucleotide-dependent stimulatory action of SUR1 on the Kir6.2 pore, resulting in markedly higher K(ATP) channel open probability in intact cells at physiological MgATP concentrations; these overactive channels remain sensitive to sulfonylurea blockade.\",\n      \"method\": \"Electrophysiological patch-clamp of mutant vs. wild-type K(ATP) channels in intact cells; clinical mutation screening of 34 neonatal diabetes patients\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional electrophysiology of mutant channels with clinical correlation, replicated across multiple mutations\",\n      \"pmids\": [\"16885549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SUR1 (ABCC8) binds ATP at NBF1 and ADP at NBF2, with the two nucleotide-binding folds working cooperatively; ADP binding/hydrolysis at SUR1 activates the K(ATP) channel, counterbalancing ATP-mediated inhibition through Kir6.2, thereby coupling metabolic state to channel activity.\",\n      \"method\": \"Biochemical nucleotide-binding and ATPase assays; functional reconstitution of K(ATP) channels with mutagenesis of NBF domains\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution and mechanistic model supported by multiple experimental approaches, widely cited foundational paper\",\n      \"pmids\": [\"10581363\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Loss-of-function ABCC8 mutations causing congenital hyperinsulinism alter intracellular trafficking of the SUR1/Kir6.2 channel complex, preventing its delivery to the plasma membrane, as shown by photolabeling studies in a reconstituted system.\",\n      \"method\": \"Photolabeling studies with reconstituted system; functional electrophysiology of beta-cells from patients; direct sequencing of all ABCC8 coding exons\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted system photolabeling plus direct functional studies in patient beta-cells\",\n      \"pmids\": [\"15579781\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Diabetogenic activating mutations in SUR1 (ABCC8) cause MgATP-dependent hyper-stimulation that compromises K(ATP) channel metabolic sensing; channel hyperactivity rises exponentially with the number of mutant SUR subunits, and these channels show attenuated tolbutamide inhibition under stimulatory conditions.\",\n      \"method\": \"Electrophysiological analysis of Kir6.2-based channels reconstituted with mutant SUR1 subunits; dose-response analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution plus mutagenesis with quantitative functional readout in single study\",\n      \"pmids\": [\"18281290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SUR1 NBF1 and NBF2 mediate nucleotide activation of the K(ATP) channel through an equilibrium allosteric mechanism; ATP/ADP binding to Kir6.2 inhibits the channel while Mg-nucleotide interactions with SUR activate it, and an allosteric model accounts for this dual regulation.\",\n      \"method\": \"Review synthesizing patch-clamp electrophysiology, mutagenesis, and equilibrium binding data; mechanistic allosteric modeling\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — synthesis of multiple rigorous electrophysiological and mutagenesis experiments with mechanistic model\",\n      \"pmids\": [\"26682803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Deletion of SUR1 NBF1 severely impairs K(ATP) channel expression (reducing total SUR1 protein levels suggesting increased degradation) and abolishes MgADP stimulation; NBF1 plays a role in channel expression regulation independent of the ER retention checkpoint and proteasomal degradation pathway.\",\n      \"method\": \"Electrophysiology of reconstituted K(ATP) channels with NBF1 deletion constructs; Western blotting; proteasomal inhibitor (MG-132) treatment; 'split' SUR1 constructs\",\n      \"journal\": \"Channels (Austin, Tex.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with deletion mutagenesis plus multiple orthogonal methods\",\n      \"pmids\": [\"18708750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"EPAC (Exchange Protein Activated by cAMP) binds directly to the intracellular loop of SUR1 (ABCC8) at amino acids 859-881; EPAC-SUR1 interaction reduces KATP channel open probability, and ablation of EPAC or expression of the binding-intercepting peptide SUR1(859-881) increases channel open probability, inhibiting glutamate release and reducing seizure vulnerability.\",\n      \"method\": \"Co-immunoprecipitation/direct binding assay; electrophysiology; in vivo mouse seizure model; dominant-negative peptide expression\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding identification plus functional electrophysiology and in vivo epistasis\",\n      \"pmids\": [\"23678128\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SUR1 (ABCC8) physically co-assembles with TRPM4 and AQP4 to form a novel heteromultimeric water/ion channel complex (SUR1-TRPM4-AQP4); the full tripartite complex is required for fast, high-capacity transmembrane water transport driving cell swelling; in a murine brain edema model, astrocytes upregulate SUR1-TRPM4, AQP4 co-associates with SUR1-TRPM4, and genetic inactivation of the SUR1-TRPM4-AQP4 solute pore blocks astrocyte swelling in vivo.\",\n      \"method\": \"Co-immunoprecipitation; Förster resonance energy transfer (FRET); calcein fluorescence cell-swelling assay in COS-7 cells; in vivo murine cold-injury model with diolistic labeling; genetic knockout\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (FRET, co-IP, reconstitution in heterologous cells, in vivo KO) in a single study\",\n      \"pmids\": [\"28906027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SUR1 (ABCC8) co-localizes and co-associates with TRPM4 in human cerebral infarct neurons and endothelial cells; TRPM4 is transcriptionally upregulated after ischemia; pharmacologic blockade of SUR1 by glibenclamide mitigates perivascular TNF labeling in a rat stroke model.\",\n      \"method\": \"Immunohistochemistry and co-immunoprecipitation in postmortem human brain; in situ hybridization; rat middle cerebral artery occlusion model with pharmacologic inhibition\",\n      \"journal\": \"Journal of neuropathology and experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-immunoprecipitation in human tissue plus animal model pharmacology, single lab\",\n      \"pmids\": [\"26172285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In perivascular astrocyte endfeet following ischemic stroke, SUR1-TRPM4 upregulation mediates Na+ influx, which drives reverse-mode NCX1 to elevate intracellular Ca2+, causing calmodulin-dependent AQP4 translocation to the plasma membrane and water influx, leading to cellular edema and brain swelling; astrocyte-specific deletion of SUR1-TRPM4 or NCX1 reduces brain swelling and improves neurological function.\",\n      \"method\": \"Mouse model of severe ischemic stroke; astrocyte-specific conditional knockout; pharmacological inhibition; calcium imaging; AQP4 surface localization assays\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — cell-type-specific genetic deletion plus pharmacological rescue with defined mechanistic pathway in vivo\",\n      \"pmids\": [\"37279286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SUR1-TRPM4 activation in BV2 microglia requires P2X7 receptor-mediated Ca2+ influx; SUR1-TRPM4-driven Na+ influx amplifies K+ efflux through K+ channels, leading to NLRP3 inflammasome activation; glibenclamide blocks SUR1-TRPM4 to inhibit this pathway and exerts direct anti-inflammatory neuroprotection independent of its anti-edema role.\",\n      \"method\": \"BV2 cell OGD/reperfusion and LPS models; Trpm4 siRNA knockdown; pharmacological inhibition with glibenclamide and 9-phenanthrol; Western blotting; rat cardiac arrest model\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown plus pharmacological inhibition with defined pathway, single lab\",\n      \"pmids\": [\"35972671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SUR1 does not functionally or structurally associate with TRPM4 in COSm6 cells; TRPM4 currents are Ca2+-activated, ATP-inhibited, and insensitive to glibenclamide/tolbutamide regardless of SUR1 co-transfection; no FRET signal was detected between TRPM4 and SUR1, contrasting with efficient FRET between Kir6.2 and SUR1.\",\n      \"method\": \"Electrophysiology patch-clamp in COSm6 cells; FRET with fluorophore-tagged subunits; co-transfection of Kir6.2, SUR1, and TRPM4\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with FRET and electrophysiology, but contradicts other published work (moderate)\",\n      \"pmids\": [\"22291026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss-of-function missense variants in ABCC8 are associated with pulmonary arterial hypertension; all evaluated ABCC8 variants decreased K(ATP) channel function in patch-clamp and rubidium flux assays in COS cells, and channel currents were pharmacologically rescued by the SUR1 activator diazoxide.\",\n      \"method\": \"Exome sequencing; patch-clamp electrophysiology; rubidium flux analysis in COS cells; pharmacological rescue with diazoxide\",\n      \"journal\": \"Circulation. Genomic and precision medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional assays (patch clamp + Rb flux) on multiple variants with pharmacological rescue\",\n      \"pmids\": [\"30354297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Combining two ABCC8 coding mutations (D1193V and R1436Q) on a single allele causes intracellular retention of the SUR1/Kir6.2 channel complex, whereas each mutation individually results in plasma membrane-localized channels; separately, G228D and D1471N mutations in cis also cause intracellular retention and loss of K(ATP) channel function.\",\n      \"method\": \"Functional electrophysiology; intracellular localization studies of channel complex trafficking\",\n      \"journal\": \"Clinical endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional studies in heterologous expression system with defined cellular phenotype, single lab\",\n      \"pmids\": [\"17466004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Activating mutations in ABCC8 account for approximately 40% of permanent neonatal diabetes cases; the K(ATP) channel composed of SUR1 and Kir6.2 is a key regulator of insulin release, with SUR1 mutations causing gain-of-channel function leading to persistent channel opening and failure of glucose-stimulated insulin secretion.\",\n      \"method\": \"Mutation screening; functional studies; clinical review\",\n      \"journal\": \"Reviews in endocrine & metabolic disorders\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — review synthesizing multiple functional studies, widely replicated finding\",\n      \"pmids\": [\"20922570\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"An ABCC8 homozygous nonsense mutation (p.Glu747*) in exon 17 causes neonatal diabetes through absence of full-length SUR1 mRNA and expression of an alternatively spliced transcript lacking exon 17; the truncated transcript enhances K(ATP) channel sensitivity to Mg-ADP/ATP, representing a gain-of-function through altered splicing rather than typical gain-of-function missense mutation.\",\n      \"method\": \"RNA studies confirming absence of full-length transcript and presence of alternatively spliced form; clinical sulfonylurea transfer\",\n      \"journal\": \"Journal of clinical research in pediatric endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — RNA mechanistic studies with clinical functional validation, single report\",\n      \"pmids\": [\"28663158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Inhibition of SUR1 by glyburide decreases vascular permeability of cerebral metastases and reduces ZO-1 gap formation in endothelial cells, suggesting SUR1 modulates blood-tumor barrier integrity through regulation of tight junction protein ZO-1.\",\n      \"method\": \"Dynamic contrast-enhanced MRI of blood-tumor barrier permeability; immunofluorescence and Western blot for SUR1 and ZO-1; in vivo rat intracranial tumor model\",\n      \"journal\": \"Neoplasia (New York, N.Y.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo pharmacological study with defined molecular readout (ZO-1), single lab\",\n      \"pmids\": [\"23633925\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Abcc8/SUR1 gene encodes alternatively spliced short isoforms (~65 kDa) in addition to the full-length protein; immunoprecipitation assays demonstrate that SUR2 short forms are part of functional channels coexisting with typical receptor forms, and SUR1 short forms alter ATP affinity; expression of SUR1 variants may be induced by brain conditions with decreased ATP (stroke, epilepsy).\",\n      \"method\": \"Western blotting with sulfonylurea binding assays; immunoprecipitation; review of experimental data\",\n      \"journal\": \"Neural regeneration research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — review synthesizing indirect evidence, identity of short forms not fully clarified\",\n      \"pmids\": [\"34380876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Targeted deletion of Sur1/Abcc8 specifically in glucagon-expressing alpha-cells using a Cre-lox approach demonstrates that KATP channels play a regulatory role in pancreatic alpha-cells, with ~41-64% recombination efficiency depending on allele configuration.\",\n      \"method\": \"Conditional knockout (Abcc8 flox mice crossed with GCG-Cre); agonist-resistance quantification; ROSA-EYFP reporter\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with quantified phenotype in defined cell type\",\n      \"pmids\": [\"24621811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ABCC8-deficient (ABCC8V187D homozygous) iPSC-derived beta-like cells secrete 3.2-fold more insulin in low glucose and fail to respond to K(ATP) channel-acting drugs; loss of SUR1 increases SC-beta cell proliferation by 61% and this proliferative phenotype is recapitulated by pharmacological K(ATP) channel inactivation in SUR1-corrected cells, revealing a novel role for K(ATP) channel activity during human islet development.\",\n      \"method\": \"iPSC differentiation; CRISPR-Cas9 mutation correction; insulin secretion assays; in vivo mouse xenograft; pharmacological K(ATP) channel manipulation\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — isogenic iPSC model with pharmacological rescue confirming mechanism, multiple functional readouts\",\n      \"pmids\": [\"33404684\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ABCC8 encodes SUR1, the regulatory ABC-transporter subunit of the K(ATP) channel (SUR1/Kir6.2 octamer), which senses cellular metabolic state by binding MgATP at NBF1 and MgADP at NBF2 to activate channel opening, counterbalancing ATP-mediated inhibition of Kir6.2, thereby coupling beta-cell metabolism to insulin secretion; gain-of-function mutations cause neonatal diabetes and MODY by hyper-stimulating the channel, while loss-of-function mutations cause congenital hyperinsulinism through impaired channel trafficking or function; in the CNS, SUR1 additionally associates with TRPM4 (and AQP4) to form cation channels in neurons and astrocytes that drive cytotoxic edema after injury, and SUR1-TRPM4-mediated Na+ influx signals through NCX1 and calmodulin to translocate AQP4 to the plasma membrane, amplifying water influx and brain swelling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ABCC8 encodes SUR1, the regulatory subunit of the octameric K(ATP) channel (SUR1/Kir6.2), which couples cellular metabolic state to membrane excitability by sensing Mg-nucleotides: ATP binding at NBF1 and ADP binding/hydrolysis at NBF2 activate the channel, counterbalancing ATP-mediated inhibition at Kir6.2, thereby controlling insulin secretion in pancreatic beta cells and glucagon release in alpha cells [PMID:10581363, PMID:26682803, PMID:24621811]. Gain-of-function mutations in ABCC8 cause neonatal diabetes by elevating MgATP-dependent channel open probability and impairing metabolic sensing, while loss-of-function mutations cause congenital hyperinsulinism through defective trafficking of the SUR1/Kir6.2 complex to the plasma membrane; both conditions remain responsive to sulfonylurea pharmacology [PMID:16885549, PMID:15579781, PMID:30354297]. In the central nervous system, SUR1 co-assembles with TRPM4 (and AQP4) to form a heteromultimeric cation/water channel complex in astrocytes, neurons, and endothelial cells after ischemic injury; SUR1-TRPM4-mediated Na⁺ influx drives reverse-mode NCX1 signaling, calmodulin-dependent AQP4 translocation to the plasma membrane, and consequent cytotoxic edema [PMID:28906027, PMID:37279286]. Loss-of-function ABCC8 variants also diminish K(ATP) channel currents in the pulmonary vasculature and are associated with pulmonary arterial hypertension [PMID:30354297].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing how SUR1 senses metabolic state resolved the fundamental question of how an ABC transporter subunit couples nucleotide hydrolysis to ion channel gating: ATP binds NBF1 and ADP binds NBF2, with cooperative Mg-nucleotide interactions at SUR1 activating the channel to counterbalance ATP inhibition at Kir6.2.\",\n      \"evidence\": \"Biochemical nucleotide-binding/ATPase assays and functional reconstitution with NBF mutagenesis\",\n      \"pmids\": [\"10581363\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of NBF1–NBF2 cooperativity not resolved at atomic level\", \"Stoichiometry of nucleotide occupancy states in the intact octamer unclear\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that loss-of-function ABCC8 mutations cause congenital hyperinsulinism by trapping the SUR1/Kir6.2 complex intracellularly established that SUR1 controls channel trafficking in addition to gating, explaining a disease mechanism distinct from altered nucleotide sensitivity.\",\n      \"evidence\": \"Photolabeling in reconstituted system plus electrophysiology in patient beta cells\",\n      \"pmids\": [\"15579781\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ER quality-control machinery recognizing misfolded SUR1 not identified\", \"Whether trafficking-defective mutants retain partial function if forced to the surface not systematically tested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying activating ABCC8 mutations in neonatal diabetes patients showed that enhanced Mg-nucleotide-dependent stimulation of SUR1 is sufficient to hold channels open and prevent insulin secretion, establishing the gain-of-function disease mechanism and demonstrating sulfonylurea sensitivity of mutant channels.\",\n      \"evidence\": \"Patch-clamp electrophysiology of mutant channels in intact cells; mutation screening of 34 neonatal diabetes patients\",\n      \"pmids\": [\"16885549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise conformational change linking NBF activation to pore opening unknown\", \"Genotype–phenotype correlations for sulfonylurea responsiveness incomplete\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Deletion of NBF1 revealed that this domain is required not only for MgADP-dependent channel activation but also for stable SUR1 protein expression via a pathway independent of the ER retention checkpoint, showing NBF1 has a structural/stability role beyond nucleotide sensing.\",\n      \"evidence\": \"Electrophysiology of reconstituted split-SUR1 constructs; Western blotting with proteasomal inhibitor treatment\",\n      \"pmids\": [\"18708750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation pathway for NBF1-deleted SUR1 not identified\", \"Whether NBF1 directly mediates protein folding or chaperone recruitment unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Quantitative reconstitution of channels with varying numbers of mutant SUR1 subunits showed that hyperactivity rises exponentially with mutant subunit number and that tolbutamide inhibition is attenuated under stimulatory conditions, explaining variable clinical severity and sulfonylurea dose requirements.\",\n      \"evidence\": \"Electrophysiological dose-response analysis of Kir6.2-based channels with graded mutant SUR1\",\n      \"pmids\": [\"18281290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo subunit stoichiometry in patient beta cells not directly measured\", \"Whether heterozygous activating mutations produce clinically relevant hyperactivity not fully resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that EPAC binds directly to the SUR1 intracellular loop (aa 859–881) and reduces K(ATP) open probability revealed a cAMP-dependent regulatory input to channel gating, linking incretin signaling to channel modulation in neurons and affecting seizure susceptibility.\",\n      \"evidence\": \"Co-immunoprecipitation, direct binding assay, electrophysiology, and in vivo mouse seizure model with dominant-negative peptide\",\n      \"pmids\": [\"23678128\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EPAC–SUR1 interaction occurs in pancreatic beta cells and affects insulin secretion not tested\", \"Structural basis of EPAC docking on the intracellular loop unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Co-immunoprecipitation and co-localization of SUR1 with TRPM4 in postmortem human stroke tissue, together with earlier negative FRET data in heterologous cells, framed a contested question about whether SUR1 physically associates with TRPM4 in a pathophysiologically relevant context.\",\n      \"evidence\": \"Co-IP and immunohistochemistry in human cerebral infarct tissue; pharmacological inhibition in rat stroke model; prior negative FRET in COSm6 cells\",\n      \"pmids\": [\"26172285\", \"22291026\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contradictory FRET results in COSm6 cells versus co-IP in native tissue not reconciled\", \"Whether an intermediate adaptor mediates the SUR1–TRPM4 interaction not excluded\", \"Single-lab co-IP in tissue without reciprocal pulldown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that SUR1, TRPM4, and AQP4 form a tripartite heteromultimeric complex required for high-capacity water transport resolved how SUR1 participates in cytotoxic edema beyond simple ion flux, and genetic ablation confirmed the complex's necessity for astrocyte swelling in vivo.\",\n      \"evidence\": \"Co-IP, FRET, calcein cell-swelling assay in COS-7 cells, and in vivo murine cold-injury model with genetic knockout\",\n      \"pmids\": [\"28906027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and architecture of the SUR1-TRPM4-AQP4 complex not structurally resolved\", \"Whether the tripartite complex forms in non-CNS tissues unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of loss-of-function ABCC8 variants in pulmonary arterial hypertension patients, with functional rescue by diazoxide, extended K(ATP) channel pathophysiology beyond endocrine disease to vascular biology.\",\n      \"evidence\": \"Exome sequencing; patch-clamp and rubidium flux assays in COS cells; pharmacological rescue\",\n      \"pmids\": [\"30354297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking reduced K(ATP) current to pulmonary vascular remodeling not delineated\", \"Whether SUR1 or SUR2 predominates in pulmonary vascular smooth muscle not clarified\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Using isogenic iPSC-derived beta cells showed that ABCC8 deficiency increases both basal insulin secretion and beta-cell proliferation, with the proliferative phenotype recapitulated by pharmacological K(ATP) blockade, revealing a developmental role for K(ATP) channel activity in human islet biology.\",\n      \"evidence\": \"iPSC differentiation with CRISPR-Cas9 correction; insulin secretion assays; in vivo xenograft; pharmacological manipulation\",\n      \"pmids\": [\"33404684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway linking K(ATP) channel closure to proliferation not identified\", \"Whether proliferative effect persists in mature beta cells unknown\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"A complete signaling cascade was mapped in perivascular astrocyte endfeet: SUR1-TRPM4 Na⁺ influx → reverse-mode NCX1 → Ca²⁺ rise → calmodulin-dependent AQP4 translocation → water influx and edema, establishing the molecular logic by which SUR1-TRPM4 amplifies brain swelling after stroke.\",\n      \"evidence\": \"Astrocyte-specific conditional knockout of SUR1-TRPM4 and NCX1 in mouse ischemic stroke model; calcium imaging; AQP4 surface localization assays\",\n      \"pmids\": [\"37279286\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this cascade operates in non-astrocytic CNS cell types not tested\", \"Calmodulin target on AQP4 or intermediate kinase not identified\", \"Relative contribution of this pathway versus other edema mechanisms not quantified\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite detailed functional understanding, high-resolution structural models of disease-mutant SUR1 channels and the SUR1-TRPM4-AQP4 complex are lacking, and the signaling pathways linking K(ATP) channel closure to beta-cell proliferation and pulmonary vascular remodeling remain uncharacterized.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structures of activating/trafficking-defective SUR1 mutants needed\", \"Mechanism coupling K(ATP) channel state to cell proliferation unknown\", \"Reconciliation of contradictory SUR1-TRPM4 FRET data across expression systems unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [1, 4, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 3, 4, 6]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [7, 9]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 7, 9, 13]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2, 13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 1, 3, 4, 6]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [1, 4, 7, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 2, 12, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 4, 6]}\n    ],\n    \"complexes\": [\n      \"K(ATP) channel (SUR1/Kir6.2 octamer)\",\n      \"SUR1-TRPM4-AQP4 complex\"\n    ],\n    \"partners\": [\n      \"KCNJ11\",\n      \"TRPM4\",\n      \"AQP4\",\n      \"RAPGEF3\",\n      \"SLC8A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}